Why Kodiak Sciences Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Kodiak Sciences Inc. KOD fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss.

Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.

Kodiak Sciences shares dipped 19.9% to $5.97 on Thursday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • Avalo Therapeutics, Inc. AVTX shares jumped 430% to $25.35 after the company announced it acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio. The company also announced a private placement financing of up to $185 million.
  • Xilio Therapeutics, Inc. XLO gained 146% to $1.58 after the company announced an exclusive license agreement with Gilead Sciences for a tumor-activated IL-12 program. The company announced a $11.3 million private placement equity financing.
  • Biodexa Pharmaceuticals Plc BDRX shares climbed 80% to $1.5395. Biodexa's MTX110 showed promise in extending life expectancy against aggressive brain cancers.
  • Ontrak, Inc. OTRK gained 55% to $0.9239.
  • Binah Capital Group, Inc. BCG gained 48% to $14.05 after dipping more than 20% on Wednesday.
  • Kidpik Corp. PIK gained 40.7% to $4.5999. Kidpik recently regained compliance with the Nasdaq minimum bid price requirement.
  • Allego N.V. ALLG rose 32.8% to $1.7650.
  • Akanda Corp. AKAN gained 28% to $0.2053 after the company announced a plan to evaluate opportunities in Bitcoin, Blockchain and AI applications in the cannabis industry.
  • Destiny Tech100 Inc. DXYZ rose 26% to $22.15.
  • REX American Resources Corporation REX gained 23.2% to $54.15 following upbeat earnings.
  • Nutriband Inc. NTRB gained 23% to $4.98. Nutriband recently provided a clinical and regulatory path overview for its AVERSA Fentanyl patch.
  • Summit Therapeutics Inc. SMMT gained 22.8% to $4.6050.
  • CERo Therapeutics Holdings, Inc. CERO gained 22.7% to $2.00.
  • Hut 8 Corp. HUT gained 20.4% to $11.87. Hut 8 Corp reported revenue of C$60.6 million for the six months ended Dec. 31, 2023.
  • Matterport, Inc. MTTR rose 16.8% to $2.2802.
  • RH RH rose 16.2% to $344.99 following the release of quarterly results. RH posted weaker-than-expected results for its fourth quarter, but issued upbeat forecast.
  • Cazoo Group Ltd CZOO gained 15.5% to $14.52 after jumping over 100% on Wednesday.
  • Sutro Biopharma, Inc. STRO surged 14.4% to $5.64. Oppenheimer analyst Jay Olson maintained Sutro Biopharma with an Outperform and maintained a $10 price target.
  • Kintara Therapeutics, Inc. KTRA shares rose 14.1% to $0.1021. Kintara Therapeutics announced expansion of REM-001 clinical study to include patients on pembrolizumab.
  • Nikola Corporation NKLA gained 12.7% to $1.0250.
  • OPKO Health, Inc. OPK climbed 12.1% to $1.1996. Labcorp announced acquisition of select assets of BioReference Health's Diagnostics Business.
  • Altimmune, Inc. ALT climbed 11.4% to $9.90. Altimmune recently released lean mass preservation data for pemvidutide and worse-than-expected fourth-quarter FY23 earnings.
  • Marathon Digital Holdings, Inc. MARA gained 10.4% to $24.37.
  • Ginkgo Bioworks Holdings, Inc. DNA rose 7.1% to $1.1786. Ginkgo Bioworks announced that it has been awarded a contract for up to $6 million from the Defense Advanced Research Projects Agency.
  • The Estée Lauder Companies Inc. EL gained 5.4% to $152.85 after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $160 to $170.

Losers

  • Primech Holdings Ltd. PMEC shares fell 46.7% to $2.07 after the company issued financial updates and corporate highlights for the six months ended Sept. 30, 2023.
  • Gamida Cell Ltd. GMDA fell 28.1% to $0.0427. Gamida Cell shares dipped over 82% on Wednesday after the company reported fourth-quarter results and disclosed the commencement of a restructuring process.
  • Data Storage Corporation DTST dipped 24% to $5.81 following fourth-quarter results.
  • urban-gro, Inc. UGRO declined 22.9% to $1.3992 after the company reported worse-than-expected fourth-quarter financial results.
  • Presto Automation Inc. PRST fell 22% to $0.1493. Presto Automation recently entered securities purchase agreements relating to the issuance and sale of 4.8 million shares
  • Tonix Pharmaceuticals Holding Corp. TNXP dipped 19.6% to $0.2629. Tonix Pharmaceuticals announced pricing of $4.4 million registered direct offering.
  • MillerKnoll, Inc. MLKN shares fell 17.2% to $25.28 as the company reported downbeat sales for its third quarter and issued weak guidance for the fourth quarter.
  • Sezzle Inc. SEZL fell 16.6% to $77.13.
  • NuCana plc NCNA fell 16.3% to $0.2616. NuCana announced a plan to implement 1-for-25 ADS ratio change.
  • SOBR Safe, Inc. SOBR fell 13.7% to $0.4460 after gaining 12% on Wednesday.
  • Murano Global Investments Plc MRNO fell 13% to $12.97.
  • 22nd Century Group, Inc. XXII fell 12.5% to $ 0.1151 as the company posted fourth-quarter results and announced stock split of 1-for-16.
  • MicroStrategy Incorporated MSTR declined 10.9% to $1,710.01.
  • Hitek Global Inc. HKIT fell 10.3% to $1.56 after gaining over 22% on Wednesday.
  • Movella Holdings Inc. MVLA fell 10.2% to $0.0678 after dipping 20% on Wednesday.
  • Abits Group Inc. ABTS fell 10.2% to $0.70.
  • Reddit, Inc. RDDT fell 9.4% to $52.32.
  • Braze, Inc. BRZE dipped 9.3% to $45.90 after the company issued soft EPS guidance for FY25.
  • The Chemours Company CC shares dropped 6.2% to $27.09 after the company reported fourth-quarter results. The company also said it identified four material weaknesses amid its internal control over financial reporting.
  • GCT Semiconductor Holding Inc, GCTS fell 5.1% to $41.77 amid volatility following the company's recently completed business combination with Concord Acquisition Corp III and NYSE debut.
  • Carnival Corporation & plc CCL fell 4% to $16.52. Carnival posted a narrower-than-expected loss for its first quarter on Wednesday.

 

Now Read This: Jim Cramer Likes Crown Castle, But Can't Recommend Archer Aviation: It Has 'No Earnings Power'

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!